Abstract
Gemcitabine potential myotoxicity has been described in several cases of radiation recall and in patients treated with gemcitabine alone or in combination with other chemotherapy agents. We report two cases of gemcitabine related myositis identified at our institution, and perform a literature review of cases which meet the criteria for gemcitabine induced myositis associated to either radiation therapy or chemotherapy alone.
Similar content being viewed by others
References
Ardavanis AS, Ioannidis GN, Rigatos GA (2005) Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel. Anticancer Res 25:523–525
Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100
Sigurgeirsson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326:363–367
Levin MI, Mozaffar T, Al-Lozi MT, Pestronk A (1998) Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology 50:764–767
Kida Y, Maeshima E, Furukawa K, Ichikawa T, Goda M, Ichinose M (2007) A case of polymyositis with a significantly high level of KL-6 associated with pancreatic cancer. Mod Rheumatol 17:262–264
Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971–982
Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner J, Kemeny N (2004) Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 100:1793–1799
Ganem G, Solal-Celigny P, Joffroy A, Tassy D, Delpon A, Dupuis O (2000) Radiation myositis: the possible role of gemcitabine. Ann Oncol 11:1615–1616
Jeter MD, Janne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, Loeffler JS, Devlin PM, Salgia R (2002) Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 53:394–400
Miura G, Matsumoto T, Tanaka N, Emoto T, Kawamura T, Matsunaga N (2003) Two cases of radiation myositis probably induced by recall phenomenon. Nippon Igaku Hoshasen Gakkai Zasshi 63:420–422
Welsh JS, Torre TG, DeWeese TL, O’Reilly S (1999) Radiation myositis. Ann Oncol 10:1105–1108
Fogarty G, Ball D, Rischin D (2001) Radiation recall reaction following gemcitabine. Lung Cancer 33:299–302
Pinson PJ, Griep C, Sanders WH, Lelie B (2006) Myositis as a ‘radiation-recall phenomenon’ following palliative chemotherapy with carboplatin-gemcitabin for non-small-cell pulmonary carcinoma. Ned Tijdschr Geneeskd 150:1891–1894
Fakih MG (2006) Gemcitabine-induced rectus abdominus radiation recall. JOP 7:306–310
Squire S, Chan M, Feller E, Mega A, Gold R (2006) An unusual case of gemcitabine-induced radiation recall. Am J Clin Oncol 29:636
Horan G, Smith SL, Podd TJ (2006) Gemcitabine-induced radiation necrosis of the pectoralis major muscle. Clin Oncol (R Coll Radiol) 18:85
O’Regan KN, Nishino M, Armand P, Kelly PJ, Hwang DG, Di Salvo D (2010) Sonographic features of pectoralis muscle necrosis secondary to gemcitabine-induced radiation recall: case report and review of current literature. J Ultrasound Med 29:1499–1502
Voorburg AM, van Beek FT, Slee PH, Seldenrijk CA, Schramel FM (2002) Vasculitis due to gemcitabine. Lung Cancer 36:203–205
Kalmadi S, McNeill G, Davis M, Peereboom D, Adelstein D, Mekhail T (2006) Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer. Med Oncol 23:507–513
Vatca M, Tejwani S, Yates T (2009) Ischemic myositis in a diabetic patient receiving chemotherapy. Community oncol 6:69
Syrios J, Kechagias G, Xynos ID, Gamaletsou MN, Papageorgiou A, Agrogiannis G, Tsavaris N (2011) Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report. BMC Gastroenterol 11:33
Wong KM, Khanna M, Wu RC, Hedley DW (2011) Gemcitabine-induced acute myositis in a patient with duodenal cancer. Clin Oncol (R Coll Radiol). doi:10.1016/j.clon.2011.02.007
Burris HA, Hurtig J 3rd (2010) Radiation recall with anticancer agents. Oncologist 15:1227–1237
Hughes BG, Stuart-Harris R (2005) Docetaxel-induced myositis: report of a novel side-effect. Intern Med J 35:369–370
Freilich RJ, Balmaceda C, Seidman AD, Rubin M, DeAngelis LM (1996) Motor neuropathy due to docetaxel and paclitaxel. Neurology 47:115–118
Semb KA, Aamdal S, Oian P (1998) Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol 16:3426–3432
Geffen DB, Horowitz J (2000) Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone. Isr Med Assoc J 2:552–553
Aapro MS, Martin C, Hatty S (1998) Gemcitabine—a safety review. Anticancer Drugs 9:191–201
Azzoli CG, Miller VA, Ng KK, Krug LM, Hensley ML, O’Reilly EM, Muller RJ, Kris MG (2003) Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature. Am J Clin Oncol 26:247–251
Acknowledgments
We thank Dr Jerome B. Posner for his advice and extremely valuable suggestions. We thank Judith Lampron for her editorial assistance.
Conflict of interest
The authors report no relevant conflict of interest
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pentsova, E., Liu, A., Rosenblum, M. et al. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review. J Neurooncol 106, 15–21 (2012). https://doi.org/10.1007/s11060-011-0672-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-011-0672-8